(secondQuint)Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma.

 To explore the effect of Lenalidomide, dexamethasone and Medi-551 on multiple myeloma cancer stem cells (CSCs).

 Myeloma CSCs will be assessed by a clonogenic assay from the bone marrow and flow cytometry from peripheral blood.

.

 Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma@highlight

This research study is being done to see if combining the investigational chemotherapy drug, MEDI-551 with the known anti-myeloma drugs, Lenalidomide and Dexamethasone will reduce your myeloma cancer stem cells.

